Joined Today: 0

AVAN Avant Immunotherapeutics, Stock Message Board

All Messages

AVAN Message Board Home | Join The AVAN Group |

#11: AVAN News AVANT Receives Payment from Paul Royalty Fund
Stock News Bot	December 1, 2005 11:14:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Dec. 1, 2005--AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that it has received the second unconditional payment of $5,000,000 from an affiliate of... view message ignore post recommend post

#10: AVAN News AVANT to Pursue Development of Avian Flu Vaccine
Stock News Bot	November 14, 2005 02:01:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Nov. 14, 2005--AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that it has formed a research team to focus on development of an avian flu vaccine... view message ignore post recommend post

#9: AVAN News AVANT To Present At Rodman & Renshaw TechVest Healthcare Conference
Stock News Bot	November 1, 2005 02:01:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Nov. 1, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT Immunotherapeutics,... view message ignore post recommend post

#8: AVAN News AVANT Immunotherapeutics Reports Third Quarter and Nine Month Financial Results
Stock News Bot	October 27, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Oct. 27, 2005--AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today reported financial results for the third quarter and nine months ended September 30, 2005. For... view message ignore post recommend post

#7: AVAN News AVANT to Report Third Quarter Fiscal 2005 Financial Results on October 27, 2005; Conference Call to Follow
Stock News Bot	October 21, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Oct. 21, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) will release its third quarter fiscal 2005 financial results before U.S. financial markets open on... view message ignore post recommend post

#6: AVAN News AVANT To Present At 2005 BIO Investor Forum
Stock News Bot	October 13, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Oct. 13, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT... view message ignore post recommend post

#5: AVAN News AVANT Completes Enrollment of TP10 Phase IIb Study in Women Undergoing Cardiac Bypass Surgery
Stock News Bot	October 11, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Oct. 11, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that it has completed enrollment of the Phase IIb trial of its complement inhibitor,... view message ignore post recommend post

#4: AVAN News AVANT To Present At The Roth Capital Partners 2005 New York Conference
Stock News Bot	September 1, 2005 01:30:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Sept. 1, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Una S. Ryan, Ph.D., President and Chief Executive Officer of AVANT... view message ignore post recommend post

#3: AVAN News AVANT Immunotherapeutics Reports Second Quarter and Six Month Financial Results
Stock News Bot	August 3, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--Aug. 3, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today reported financial results for the second quarter and six months ended June 30, 2005. The company... view message ignore post recommend post

#2: AVAN News New Cholera Vaccine is Safe and Immunogenic in Infants and Children; AVANT Reports Positive Phase II Study Results of Single Dose Oral CholeraGarde(R)
Stock News Bot	July 27, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--July 27, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today a breakthrough in the control of cholera with positive preliminary results from a Phase... view message ignore post recommend post

#1: AVAN News AVANT and Harvard Medical School Receive NIH Funding for Production of a Thermostable Cholera Vaccine
Stock News Bot	July 18, 2005 01:00:00 AM
NEEDHAM, Mass.--(BUSINESS WIRE)--July 18, 2005--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Harvard Medical School will receive nearly $500,000 from the National Institutes... view message ignore post recommend post

Group Home | Login if you want to post a message